Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Sunesis Pharmaceuticals expands hematology pipeline with two kinase inhibitor programs

Jan. 13, 2014

University of Massachusetts Medical School to develop PiZ antibody for the Alpha-1 Project

Jan. 13, 2014

MedImmune and Immunocore enter agreement to develop cancer therapies

Jan. 13, 2014

XTL Biopharmaceuticals in-licenses hCDR1 for lupus

Jan. 13, 2014

Bayer and Peking University establish new research center in Beijing

Jan. 13, 2014

Isarna Therapeutics and Santaris Pharma to develop next-generation oligonucleotides

Jan. 13, 2014

Crystal Bioscience and Boehringer Ingelheim enter therapeutic antibody collaboration

Jan. 10, 2014

Five Prime Therapeutics enters into antibody collaboration with Adimab

Jan. 10, 2014

Leica Biosystems to develop companion diagnostic for Arno's targeted oncology therapy onapristone

Jan. 10, 2014

Eddingpharm acquires rights to several oncology assets from ACT Biotech

Jan. 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...